10-104002250-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000369755.4(SLK):c.1072T>A(p.Cys358Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000292 in 1,611,972 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
SLK
ENST00000369755.4 missense
ENST00000369755.4 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 3.71
Genes affected
SLK (HGNC:11088): (STE20 like kinase) Enables protein homodimerization activity and protein serine/threonine kinase activity. Involved in several processes, including cytoplasmic microtubule organization; protein autophosphorylation; and regulation of focal adhesion assembly. Located in perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0610826).
BS2
High AC in GnomAd4 at 22 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLK | NM_014720.4 | c.1072T>A | p.Cys358Ser | missense_variant | 9/19 | ENST00000369755.4 | NP_055535.2 | |
SLK | NM_001304743.2 | c.1072T>A | p.Cys358Ser | missense_variant | 9/18 | NP_001291672.1 | ||
SLK | XM_011540401.4 | c.993+678T>A | intron_variant | XP_011538703.1 | ||||
SLK | XM_047426039.1 | c.993+678T>A | intron_variant | XP_047281995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLK | ENST00000369755.4 | c.1072T>A | p.Cys358Ser | missense_variant | 9/19 | 1 | NM_014720.4 | ENSP00000358770 | P1 | |
SLK | ENST00000335753.8 | c.1072T>A | p.Cys358Ser | missense_variant | 9/18 | 1 | ENSP00000336824 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152202Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
21
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000480 AC: 12AN: 250204Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135322
GnomAD3 exomes
AF:
AC:
12
AN:
250204
Hom.:
AF XY:
AC XY:
5
AN XY:
135322
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1459652Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 725810
GnomAD4 exome
AF:
AC:
25
AN:
1459652
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
725810
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000144 AC: 22AN: 152320Hom.: 1 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74484
GnomAD4 genome
AF:
AC:
22
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.1072T>A (p.C358S) alteration is located in exon 9 (coding exon 9) of the SLK gene. This alteration results from a T to A substitution at nucleotide position 1072, causing the cysteine (C) at amino acid position 358 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Gain of phosphorylation at C358 (P = 0.0068);Gain of phosphorylation at C358 (P = 0.0068);
MVP
MPC
0.053
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at